Biostatistics & Population Health

Notifiable diseases and public health reporting

Clinical Overview and When to Suspect a Reportable Condition

— Reporting is mandated at the state level; each state maintains its own list, which usually aligns with the CDC's Nationally Notifiable Diseases List curated by CSTE (Council of State and Territorial Epidemiologists).

— CDC aggregates de-identified data via NNDSS (National Notifiable Diseases Surveillance System) and publishes weekly in MMWR.

— Reporting is not a HIPAA violation — the public health exception (45 CFR §164.512(b)) permits disclosure without patient authorization.

— Any suspected (not just confirmed) case of TB, measles, pertussis, meningococcal disease, rabies exposure, or a viral hemorrhagic fever.

— Any cluster — two or more cases of foodborne illness, healthcare-associated infections, or unexplained deaths.

— Sexually transmitted infections (syphilis, gonorrhea, chlamydia, HIV, chancroid).

— Vaccine-preventable diseases (measles, mumps, rubella, polio, diphtheria, tetanus, varicella in many states).

— Bioterrorism-associated agents (anthrax, smallpox, plague, botulism, tularemia, VHF) → immediate reporting.

— Animal bites (rabies risk), lead poisoning, certain cancers, and birth defects in many jurisdictions.

Board pearl: Reporting is based on clinical suspicion, not laboratory confirmation. A child with a morbilliform rash, fever, coryza, and Koplik spots gets reported to the health department before measles IgM returns. Waiting for confirmation is the wrong answer on Step 3 — early reporting drives contact tracing and post-exposure prophylaxis windows (e.g., MMR within 72 h, Ig within 6 days).

Notifiable diseases are conditions for which routine, timely case reports are legally required from clinicians and labs to public health authorities to enable outbreak detection, contact tracing, and population-level surveillance.

Legal framework

When to suspect a reportable scenario on a Step 3 stem

Presentation Patterns and Key History

— Fever + rash in a returning traveler → measles, rubella, dengue, chikungunya, viral hemorrhagic fever, typhoid (rose spots).

— Cough >3 weeks + hemoptysis + night sweats + weight loss → TB, immediately reportable on suspicion.

— Paroxysmal cough with inspiratory whoop or post-tussive emesis in an unvaccinated child → pertussis.

— Acute flaccid paralysis in a child → polio surveillance mandate worldwide.

— Bloody diarrhea after ground beef or petting zoo → STEC O157:H7 / HUS — reportable.

— Cluster of GI illness after shared meal → foodborne outbreak.

— Unexplained encephalitis after bat exposure or animal bite → rabies.

— Genital ulcer + lymphadenopathy or painless chancre → syphilis, chancroid.

— Healthcare worker needlestick source positive for HIV/HBV/HCV → occupational exposure, separate reporting pathway.

— Travel (countries, dates, rural vs urban, mosquito/tick exposure).

— Occupational exposure (healthcare, daycare, food handler, farm, lab).

— Sick contacts and household clustering.

— Immunization status, including recent live-vaccine receipt.

— Animal exposures — bats, dogs, rodents, livestock, ticks.

— Sexual history with the 5 Ps for STI reportability decisions.

— Food history — undercooked meat, raw milk, soft cheese, shellfish, sprouts.

Step 3 management: When the vignette mentions a food handler, daycare worker, or healthcare worker with a reportable GI or respiratory pathogen, the answer is both report and work restriction until clearance criteria are met (e.g., 2 negative stool cultures 48 h apart for Shigella in food handlers in many states).

The "reportable disease" question on Step 3 typically embeds the actual clinical vignette inside a public health decision. Recognize the trigger features that should make you reach for the phone.

Classic presentation triggers

Key history elements to extract from the stem

Physical Exam Findings and Initial Bedside Assessment

— Koplik spots (bluish-white papules on buccal mucosa) → measles. Report before serology.

— Posterior cervical/occipital lymphadenopathy + rash → rubella.

— Parotitis, bilateral in an adolescent → mumps.

— Pseudomembrane on tonsils/pharynx that bleeds when scraped → diphtheria.

— Trismus, risus sardonicus, opisthotonos → tetanus.

— Eschar with regional lymphadenopathy → tularemia, anthrax, rickettsial disease.

— Petechial/purpuric rash with fever and meningismus → meningococcemia — immediate report + droplet isolation + chemoprophylaxis for close contacts.

— Bull's-eye erythema migrans → Lyme disease (reportable in most states).

— Respiratory rate, SpO₂, work of breathing → airborne isolation needs (TB, measles, varicella).

— Rash distribution and stage → droplet vs airborne vs contact.

— Mental status → severity flag for meningococcal, encephalitis, rabies.

— Airborne (N95 + negative pressure): TB, measles, varicella, smallpox, SARS/MERS, novel respiratory pathogens.

— Droplet (surgical mask): pertussis, meningococcus, influenza, mumps, rubella, diphtheria.

— Contact: C. difficile, MDROs, scabies, VHF (plus airborne/standard).

— Standard precautions only: most STIs, HIV, HBV/HCV.

CCS pearl: On a CCS case with suspected measles or TB, the order "isolate patient — airborne precautions" should appear within the first few minutes, alongside "notify public health department." Delaying either costs points and clinical realism.

Exam serves two purposes in reportable-disease vignettes: confirm clinical suspicion to justify immediate reporting, and identify severity requiring isolation or escalation.

Pathognomonic or near-pathognomonic findings that should trigger reporting on the spot

Isolation-relevant findings to assess at bedside

Infection control posture by clinical phenotype

Diagnostic Workup — Initial Labs, Imaging, and Confirmatory Testing

— CBC with differential, CMP, CRP, blood cultures ×2 if febrile, urinalysis.

— Pregnancy test in reproductive-age women — alters therapy (e.g., doxycycline, fluoroquinolones).

— HIV test if any STI, TB, or opportunistic infection is suspected.

— TB: CXR (upper-lobe cavitation, hilar adenopathy), 3 sputum AFB smears + cultures + NAAT (Xpert MTB/RIF), IGRA or TST for latent screening of contacts.

— Measles: measles IgM + RT-PCR from nasopharyngeal/throat swab and urine; notify lab in advance — many require state public health lab.

— Pertussis: NP swab PCR (highest yield weeks 0–4); culture early; serology late.

— Meningococcal disease: blood culture + LP (CSF Gram stain, culture, PCR) — do not delay antibiotics for LP.

— Syphilis: nontreponemal (RPR/VDRL) + treponemal (FTA-ABS/TP-PA) — reverse-sequence algorithm now common.

— Gonorrhea/chlamydia: NAAT urine or site-specific swab.

— HIV: 4th-gen Ag/Ab combo + confirmatory differentiation assay + HIV RNA if acute suspected.

— STEC/HUS: stool culture on SMAC + Shiga toxin EIA + PCR; CBC, peripheral smear, LDH, haptoglobin, creatinine.

— Foodborne outbreak: stool culture, ova/parasites, C. difficile toxin, norovirus PCR depending on epidemiology.

— Hepatitis A/B/C: acute panel (HAV IgM, HBsAg, anti-HBc IgM, HCV Ab + RNA).

— Many state labs require prior notification before sending specimens for select agents (VHF, smallpox, anthrax) — never ship without calling.

Board pearl: A CT4 case count in a school outbreak still needs individual case reports for each suspected case — aggregate reporting does not replace per-case notification on Step 3.

Reporting does not wait for confirmation, but appropriate testing supports case classification (suspect, probable, confirmed) per CSTE definitions.

Universal initial workup for suspected reportable infection

Disease-specific initial testing

Coordination with the public health lab

Diagnostic Workup — Advanced or Confirmatory Studies

— TB confirmation: liquid culture (MGIT, 1–3 weeks), drug-susceptibility testing, whole-genome sequencing for outbreak linkage; contact investigation via local health dept generates TST/IGRA in close contacts.

— Measles/rubella: genotyping at CDC distinguishes wild-type from vaccine-strain and traces importation source.

— Foodborne outbreaks: PulseNet uses whole-genome sequencing of Salmonella, Listeria, E. coli, Campylobacter isolates to detect multistate clusters.

— Influenza: subtyping (H1, H3, novel) — novel influenza A is immediately notifiable.

— HIV: genotypic resistance testing at diagnosis; CD4 and viral load for staging; all new HIV diagnoses reported by name in all 50 states.

— Syphilis: darkfield microscopy of chancre exudate (rarely available); CSF VDRL if neurosyphilis suspected.

— Viral hepatitis: HBV DNA, HCV RNA + genotype; distinguish acute vs chronic for reporting category.

— Public health may order water, food, or environmental sampling; the clinician's role is to provide a clean exposure history and trigger the response.

— Cluster identification often relies on the index physician's report — one observant clinician calling about three children with bloody diarrhea from the same daycare initiates the entire investigation.

— Suspect: clinical syndrome only.

— Probable: clinical + epidemiologic link or supportive lab.

— Confirmed: definitive lab criteria met.

— All three categories are typically reportable, though urgency differs.

Key distinction: Latent TB (positive IGRA/TST, normal CXR, asymptomatic) is reportable in many but not all states — but active TB is reportable everywhere, immediately. On Step 3, default to reporting both when in doubt.

Once initial testing is sent, confirmatory and molecular studies refine case classification and guide public health response (genotyping for transmission chains, antimicrobial resistance surveillance).

Advanced studies by category

Environmental and exposure investigations

Case classification framework (CSTE)

Risk Stratification and Reporting Urgency Tiers

— Anthrax, botulism, plague, smallpox, tularemia, viral hemorrhagic fevers (the Category A bioterrorism agents).

— Measles, rubella, polio, diphtheria — vaccine-preventable with rapid transmission.

— Novel influenza A, SARS-CoV-2 variants of concern, MERS-CoV.

— Meningococcal disease, pertussis in some states.

— Suspected foodborne or waterborne outbreaks.

— Rabies (human or animal exposure).

— Healthcare-associated outbreaks.

— Most STIs (syphilis, gonorrhea, chlamydia, HIV).

— Hepatitis A, B, C.

— Salmonella, Shigella, Campylobacter, Giardia, Cryptosporidium.

— Lyme disease, ehrlichiosis, RMSF, West Nile, dengue, Zika.

— TB (active disease is often "within 24 h" — check state, but treat as urgent).

— Lead poisoning (blood lead ≥3.5 µg/dL in children per 2021 CDC reference).

— Who reports: physicians, PAs/NPs, labs, infection preventionists, schools, daycares, correctional facilities — all are mandated reporters in most jurisdictions.

— How: state-specific online portals, fax, phone for urgent diseases.

— What: patient identifiers, demographics, clinical syndrome, lab results, exposure history, treatment.

— Penalty for failure: civil or misdemeanor liability under state public health law.

Step 3 management: If a question asks "what is the next step?" and you have suspected meningococcal disease, the correct sequence is (1) empiric ceftriaxone + vancomycin + droplet isolation → (2) blood cultures + LP → (3) notify public health → (4) ciprofloxacin/rifampin chemoprophylaxis for close contacts, with reporting initiated in parallel, not after.

Not every reportable disease demands the same response speed. States categorize diseases into tiered urgency, and Step 3 expects you to know the extremes.

Immediately notifiable (phone the health department, often <24 h, sometimes within hours)

Routinely notifiable (within ~1 week, often via electronic lab reporting)

Reporting mechanics

Pharmacotherapy — First-Line Empiric Regimens for Common Reportable Infections

— Active pulmonary TB: RIPE — rifampin, isoniazid (+ pyridoxine), pyrazinamide, ethambutol — × 2 months, then RI × 4 months. DOT (directly observed therapy) coordinated by health department.

— Latent TB: isoniazid + rifapentine weekly × 12 weeks (3HP), or rifampin × 4 months, or INH × 9 months.

— Meningococcal meningitis: ceftriaxone 2 g IV q12h ± vancomycin; chemoprophylaxis for close contacts = ciprofloxacin 500 mg PO ×1, rifampin 600 mg PO q12h ×4 doses, or ceftriaxone 250 mg IM ×1.

— Pertussis: azithromycin 500 mg day 1, then 250 mg days 2–5. Postexposure prophylaxis for household and high-risk contacts with same regimen, regardless of vaccination status.

— Syphilis: benzathine penicillin G 2.4 million units IM ×1 (early); ×3 weekly doses for late latent/unknown duration. Partner notification and treatment mandatory.

— Gonorrhea: ceftriaxone 500 mg IM ×1 (1 g if ≥150 kg). Treat partners from last 60 days (expedited partner therapy where legal).

— Chlamydia: doxycycline 100 mg BID ×7 days (azithromycin 1 g ×1 if pregnant or adherence concern).

— HIV: initiate ART at diagnosis (e.g., bictegravir/TAF/FTC); link to care, report by name.

— Measles exposure PEP: MMR within 72 h if eligible, or IVIG within 6 days for high-risk (pregnant, immunocompromised, infants <12 mo).

— Rabies PEP: wound cleansing + HRIG infiltrated into wound + rabies vaccine on days 0, 3, 7, 14 (+28 if immunocompromised).

— Anthrax PEP: ciprofloxacin or doxycycline × 60 days + vaccine series.

Board pearl: Doxycycline is now first-line for chlamydia in non-pregnant patients (2021 CDC update) — superior cure rates for rectal infection. Azithromycin remains preferred only in pregnancy.

Empiric treatment frequently begins before confirmation, especially for high-mortality or high-transmission diseases. Public health reporting and chemoprophylaxis of contacts run in parallel.

High-yield regimens for reportable infections

Expanded Pharmacology and Outbreak Pharmacy Logistics

— Measles outbreak: vaccinate all susceptible contacts within 72 h; if contraindicated, give IVIG within 6 days. Verify two-dose MMR history for healthcare workers, students, international travelers.

— Hepatitis A outbreak: HAV vaccine within 14 days of exposure for healthy ages 1–40; immunoglobulin for <1 yr, >40 yr, immunocompromised, chronic liver disease.

— Hepatitis B exposure: HBIG + vaccine series for unvaccinated exposed persons within 24 h.

— Varicella exposure: VZV vaccine within 5 days for susceptible immunocompetent; VariZIG for pregnant, immunocompromised, neonates.

— Meningococcal outbreak: MenACWY or MenB vaccination of at-risk cohort (e.g., college dormitory).

— Strategic National Stockpile deploys ciprofloxacin/doxycycline (anthrax), smallpox vaccine, antitoxins (botulism, diphtheria), and oseltamivir during pandemics.

— Diphtheria antitoxin is available only through CDC — call the CDC Emergency Operations Center (770-488-7100) 24/7.

— Botulism antitoxin similarly CDC-released; clinical suspicion alone justifies request.

— MDR-TB and XDR-TB are separately tracked; treatment requires specialist consultation and second-line agents (bedaquiline, linezolid, pretomanid for the BPaL regimen in eligible patients).

— Gonorrhea resistance: ceftriaxone dose was increased to 500 mg in 2020 due to rising MIC; treatment failures should be cultured and reported for the GISP surveillance program.

— DOT and 90/90/90 HIV targets — adherence directly affects community transmission.

CCS pearl: When a CCS case involves diphtheria, botulism, or anthrax, the first three orders should include (1) empiric antibiotics, (2) call CDC for antitoxin, and (3) notify the state health department — all before confirmatory testing returns.

Public health response often requires mass prophylaxis or vaccination campaigns, and Step 3 may test the logistics and indications.

Vaccine-mediated containment

Antiviral and antimicrobial stockpiles

Drug-resistance surveillance

Counseling on adherence

Special Populations — Elderly and Renal/Hepatic Impairment

— TB reactivation is more common; nursing home outbreaks must be reported and trigger contact tracing of all residents and staff.

— Influenza and pneumococcal disease — invasive pneumococcal disease is reportable in many states; ensure PCV20 or PCV15+PPSV23 completion.

— Shingles: not nationally notifiable in most states but tracked locally; counsel on Shingrix (RZV) at age ≥50.

— Foodborne illness in long-term care — Listeria, Salmonella, norovirus outbreaks require facility-wide reporting and cohorting.

— Drug dosing: adjust isoniazid, rifampin (hepatotoxicity), ethambutol (renal — check CrCl, monitor visual acuity), fluoroquinolones (tendon rupture, QT), aminoglycosides (nephro/ototoxicity).

— Ethambutol: reduce frequency if CrCl <30 (e.g., 3× weekly).

— Pyrazinamide: 3× weekly dosing in advanced CKD.

— Acyclovir, ganciclovir, tenofovir DF: renal dose adjustment; consider TAF over TDF in CKD.

— Penicillin G for syphilis: usually safe across renal function but watch for cumulative dose effects.

— RIPE regimen — all four agents are hepatotoxic except ethambutol. Baseline LFTs, monitor monthly; hold if ALT >3× ULN with symptoms or >5× ULN asymptomatic.

— HCV treatment: DAA regimens (glecaprevir/pibrentasvir, sofosbuvir/velpatasvir) — all new HCV diagnoses reportable; treat all without restriction in current US guidelines.

— HBV treatment: entecavir or tenofovir (TAF preferred in renal/bone disease).

Step 3 management: A 78-year-old nursing home resident with new active TB requires (1) airborne isolation transfer, (2) immediate health department notification, (3) RIPE initiation with renal/hepatic dose check, and (4) facility-wide contact investigation — the nursing home itself becomes the index for a public health response.

Reporting obligations are identical regardless of age or organ function, but treatment and surveillance nuances shift.

Elderly considerations

Renal impairment

Hepatic impairment

Special Populations — Pregnancy, Pediatrics, and Other Subgroups

— Syphilis in pregnancy: universal screening at first prenatal visit, third trimester (28 wks), and at delivery in high-prevalence areas. Treat with penicillin only — desensitize if allergic. Congenital syphilis is separately reportable and has surged in the US.

— HIV in pregnancy: universal opt-out screening; ART throughout pregnancy; perinatal HIV exposure is reportable in all states.

— Hepatitis B: screen all pregnant women (HBsAg); infants of HBsAg+ mothers receive HBIG + vaccine within 12 h of birth.

— Gonorrhea/chlamydia: screen all <25 y and high-risk pregnant women; treat with ceftriaxone + azithromycin (azithro preferred over doxy in pregnancy).

— Zika, rubella, CMV, toxoplasmosis, parvovirus B19: Zika and rubella explicitly reportable; congenital rubella syndrome is a sentinel event.

— Listeria in pregnancy: ampicillin + gentamicin; report — often linked to deli meats, soft cheese, cantaloupe outbreaks.

— Vaccine-preventable diseases (measles, mumps, rubella, pertussis, varicella, polio, Hib, hepatitis A/B) are aggressively tracked.

— Lead poisoning: report blood lead ≥3.5 µg/dL (CDC reference value, 2021). Environmental investigation triggered at ≥5 µg/dL in many states.

— Congenital infections (CMV, syphilis, toxoplasmosis, rubella, HIV, HBV, Zika) — each reportable.

— Child abuse: separately mandated reporting to CPS, not to the health department — different pathway, same legal duty.

— Healthcare workers: occupational TB, HBV, HCV, HIV exposures via OSHA bloodborne pathogen standard.

— Refugees/immigrants: domestic medical exam screens for TB, HIV, hepatitis, STIs, parasites — all reportable per state rules.

Board pearl: A pregnant woman with a penicillin allergy and syphilis must be desensitized and treated with penicillin — no alternative is acceptable for preventing congenital syphilis. Report the case the same day.

Reportable diseases in these groups carry both individual risk and vertical/community transmission implications.

Pregnancy

Pediatrics

Other subgroups

Complications and Adverse Outcomes of Delayed Reporting

— Measles: pneumonia, encephalitis, SSPE years later; outbreaks in unvaccinated clusters.

— Meningococcal disease: Waterhouse-Friderichsen syndrome, limb loss, deafness; secondary cases in close contacts if chemoprophylaxis not deployed.

— TB: cavitary disease, miliary spread, transmission to household and workplace; MDR/XDR emergence with poor adherence.

— Syphilis: neurosyphilis, cardiovascular syphilis, congenital syphilis (stillbirth, Hutchinson teeth, saddle nose, snuffles).

— Pertussis: apnea and death in infants <6 months — household transmission from undiagnosed adolescents.

— STEC/HUS: AKI, thrombotic microangiopathy, neurologic injury; daycare-associated outbreaks if not contained.

— Foodborne outbreaks: multistate spread if PulseNet detection is delayed.

— Outbreak amplification: each missed index case can seed exponential spread (measles R₀ 12–18).

— Delayed contact tracing: PEP windows close (measles MMR 72 h, rabies before symptom onset, HIV nPEP 72 h, pertussis ~21 days).

— Loss of herd immunity tracking: schools/daycares cannot implement exclusion policies.

— Civil penalties, license action by state medical board, criminal misdemeanor in some states.

— Malpractice exposure if a downstream patient acquires a preventable infection traceable to non-reporting.

— Failure to report is a reportable safety event within many hospital systems' just-culture frameworks.

Key distinction: Reporting is not breach of confidentiality. HIPAA explicitly permits disclosure to public health authorities. A patient cannot "opt out" of measles or TB reporting. They can decline contact tracing assistance, but the case itself must still be reported.

Failure to report — or delayed reporting — carries clinical, legal, and population-level consequences that Step 3 may probe.

Clinical complications by disease

Public health consequences

Legal and professional consequences

Patient safety event categorization

When to Escalate — Inpatient Triage, ICU, and Consultation Pathways

— Active pulmonary TB with hemoptysis, hypoxia, or social inability to isolate at home → admit to negative-pressure room.

— Meningococcal disease suspicion → ICU-level monitoring for shock, DIC, adrenal hemorrhage.

— Severe measles with pneumonia or encephalitis, especially infants and immunocompromised.

— STEC/HUS with AKI, anemia, thrombocytopenia → admit; nephrology consult; avoid antibiotics and antimotility agents (worsens HUS).

— Severe pertussis in infant <4 months → admit for apnea monitoring.

— Diphtheria with airway compromise → ICU, antitoxin, possible tracheostomy.

— Viral hemorrhagic fever suspicion → biocontainment unit; CDC and state lab activation.

— Infectious Disease: TB, HIV, syphilis (especially neuro/ocular), VHF, novel pathogens.

— Infection Prevention/Hospital Epidemiology: any healthcare-associated cluster.

— Public Health Department: not a "consult" — it is a legal report, performed in parallel with ID input.

— Toxicology: lead poisoning workup and chelation thresholds (succimer at ≥45 µg/dL in children; EDTA/dimercaprol at >70 or encephalopathy).

— OB: any reportable infection in pregnancy.

— Hemodynamically stable, able to isolate, social support adequate, follow-up within 24–72 h.

— Examples: uncomplicated chlamydia, gonorrhea, early syphilis, mild HAV, latent TB, lab-only HCV/HBV detection in stable patient.

CCS pearl: For a CCS pediatric measles case, the correct early actions are (1) airborne isolation with N95, (2) call the state health department, (3) supportive care + vitamin A (200,000 IU × 2 days; reduces mortality), (4) MMR/IVIG to susceptible contacts, and (5) admit if pneumonia, encephalitis, or dehydration.

Reportable disease management often parallels clinical escalation. The reporting step does not replace standard severity triage.

Inpatient admission triggers

Consultations

Outpatient management appropriate when

Key Differentials — Same-Category (Infectious) Mimics

— Measles (reportable) vs roseola (not), drug rash (not), Kawasaki (not nationally notifiable but clinical urgency).

— Rubella (reportable) vs fifth disease/parvovirus B19 (not nationally reportable in most states).

— Scarlet fever / GAS pharyngitis: invasive GAS is reportable; non-invasive strep throat is not.

— Meningococcemia (reportable, immediate) vs RMSF (reportable, routine) vs DIC from sepsis.

— TB vs NTM (M. avium, M. abscessus) — NTM not reportable, no contact tracing.

— Pertussis vs viral bronchiolitis, mycoplasma, postviral cough.

— Legionella (reportable) vs other CAP (not).

— Novel influenza A (immediately reportable) vs seasonal influenza (aggregate surveillance only).

— STEC, Salmonella, Shigella, Campylobacter, Cyclospora, Cryptosporidium, Vibrio — all reportable.

— Norovirus — reportable as outbreak, not individual case in most states.

— C. difficile — reportable as healthcare-associated infection through NHSN.

— Syphilis, chancroid, granuloma inguinale, LGV — reportable.

— HSV — not nationally notifiable.

— HAV, HBV, HCV acute and chronic — all reportable.

— HEV — reportable in some states; emerging.

— Autoimmune or drug-induced hepatitis — not reportable.

Board pearl: When the stem describes a child with paroxysmal cough, post-tussive emesis, and a normal CXR, the answer is pertussis NP PCR + macrolide + report + household prophylaxis — not "wait for serology." Serology is only useful in late disease.

A reportable infection vignette is often a differential exercise — distinguishing reportable from non-reportable look-alikes determines whether the phone call happens.

Rash + fever

Respiratory

Diarrheal

Genital ulcer/STI

Hepatitis

Key Differentials — Other-Category (Non-Infectious and Environmental) Reportables

— Lead poisoning: blood lead ≥3.5 µg/dL (children), occupational thresholds for adults (OSHA).

— Pesticide exposures: organophosphate, carbamate poisonings.

— Carbon monoxide poisoning: reportable in many states.

— Mercury, arsenic, cadmium elevated levels.

— Heat-related illness deaths: reportable in some jurisdictions.

— All malignancies are reportable to state cancer registries (SEER feeds into NCI surveillance) — typically by pathology labs, but clinicians have backstop duty.

— Birth defects registries in most states (neural tube defects, congenital heart disease, congenital infections).

— Newborn screening abnormalities (PKU, CF, sickle cell, hypothyroidism) — separately tracked.

— Gunshot/stab wounds: mandatory reporting to law enforcement, not health dept.

— Suspected child, elder, or dependent adult abuse: mandated reporting to CPS/APS within hours.

— Intimate partner violence: mandatory reporting varies by state; many require only if a weapon caused injury.

— Animal bites: reportable for rabies surveillance.

— Sudden unexpected infant death (SUID/SIDS): reportable to medical examiner.

— Maternal mortality: reviewed by state maternal mortality review committees.

— Adverse vaccine events: VAERS (not a health dept channel, but federally required).

— Adverse drug events: FDA MedWatch (voluntary for clinicians, mandatory for manufacturers).

Key distinction: Gunshot wounds → police. Child abuse → CPS. Measles → state health department. Vaccine reaction → VAERS. Drug side effect → MedWatch. Step 3 loves to swap these channels — match the pathway to the event type.

Many reportable conditions are not infections. Step 3 expects awareness of these distinct surveillance categories.

Environmental and occupational

Cancer

Birth defects and congenital conditions

Injury and violence

Other

Secondary Prevention, Discharge Planning, and Longitudinal Care

— Active TB: DOT arranged with health dept, isolation plan, monthly LFTs, sputum conversion check at 8 weeks, contact investigation list given to public health.

— HIV: link to ART within days, baseline labs (CD4, VL, resistance, HBV/HCV, STI panel, TB screen), partner services consent, vaccine update (HepA, HepB, HPV, pneumococcal, meningococcal, influenza).

— Syphilis: repeat RPR at 6 and 12 months (HIV-negative) or 3, 6, 9, 12, 24 months (HIV-positive); 4-fold titer drop = success.

— Gonorrhea/chlamydia: test of reinfection (not cure) at 3 months; expedited partner therapy.

— HBV chronic: 6-monthly ALT and HBV DNA; HCC screening with US ± AFP every 6 months in cirrhosis or selected non-cirrhotic carriers.

— HCV cured: SVR confirmation at 12 weeks post-therapy; ongoing HCC surveillance if cirrhosis present.

— Pertussis household: Tdap update for all household contacts ≥7 years old not current.

— Outbreak settings: catch-up immunization for measles, mumps, varicella, polio, hepatitis A.

— Adult vaccine review at every reportable-disease visit — Tdap, Td booster q10y, influenza, pneumococcal, RSV ≥60, zoster ≥50, HPV through 26 (shared decision 27–45).

— STI risk reduction, condom use, PrEP (tenofovir/emtricitabine or cabotegravir LA) for high-risk HIV-negative partners.

— Doxy-PEP (doxycycline 200 mg within 72 h post-sex) for MSM/transgender women at high STI risk — 2024 CDC guidance.

— Smoking cessation, ETOH counseling — especially TB, HCV, HBV.

Step 3 management: After treating early syphilis with benzathine penicillin, the correct outpatient plan is RPR at 6 and 12 months, repeat HIV testing at 3 months, partner notification through health department services, and immediate retreatment if titer fails to drop 4-fold by 12 months.

Once the immediate report is filed, the clinician's longitudinal role centers on secondary prevention, vaccination, contact follow-up, and re-screening.

Discharge bundle for reportable infections

Vaccination as secondary prevention

Behavioral and counseling layer

Follow-Up, Monitoring Parameters, and Counseling

— TB therapy: monthly LFTs (especially with hepatitis risk), monthly visual acuity + color vision (ethambutol), sputum cultures monthly until conversion, weight, adherence via DOT logs.

— HIV: viral load q3 months until suppressed, then q6 months; CD4 q6 months until >300 stably; STI screen q3–6 months; renal function with TDF.

— HCV after DAA: SVR12 (HCV RNA undetectable 12 weeks after EOT).

— HBV on therapy: HBV DNA, ALT q3–6 months; HBsAg/anti-HBs annually for seroconversion.

— Lead poisoning child: repeat venous lead per CDC schedule (e.g., 3.5–9.9 µg/dL → recheck 1–3 months; ≥10 µg/dL → environmental investigation, more frequent labs).

— Pertussis cough: may persist 6–10 weeks ("100-day cough") even after antibiotics — counsel on natural history.

— Measles: isolate until 4 days after rash onset.

— Pertussis: exclude from school/daycare/work until 5 days of macrolide completed.

— Active TB: home isolation until 3 consecutive negative AFB smears, clinical improvement, and 2 weeks of effective therapy.

— Food handlers with Shigella, Salmonella Typhi, STEC, Hep A: state-defined clearance criteria, often 2 negative stool specimens.

— Healthcare workers: occupational health clearance required.

— Adherence is a population-health issue: incomplete TB therapy creates MDR-TB; incomplete syphilis treatment risks neurosyphilis and ongoing transmission.

— Vaccine misinformation: address concerns nonjudgmentally; document refusal; offer at every visit.

Board pearl: A school nurse asks when a child with measles can return to class. Correct answer: 4 days after rash onset, assuming clinical recovery — not "after rash resolves." This is the exclusion period codified by ACIP and CDC.

Each reportable disease has discrete monitoring metrics expected on Step 3.

Monitoring metrics

Return-to-activity rules

Counseling and patient education

Ethical, Legal, and Patient Safety Considerations

— 45 CFR §164.512(b) explicitly permits PHI disclosure to public health authorities without patient authorization for surveillance, investigations, and interventions.

— Tell the patient: "I'm legally required to report this; the health department may contact you or your partners."

— Reporting does not require patient consent and is not breach of confidentiality.

— Provider referral: clinician reports to health dept; disease intervention specialists contact partners without disclosing index patient.

— Patient referral: patient notifies partners directly.

— Expedited Partner Therapy (EPT): prescribing for the partner without an exam — legal in most US states for chlamydia and gonorrhea; check local rules.

— HIV-specific criminal exposure laws exist in many states; some require disclosure to known sexual/needle-sharing partners.

— Generally, the public health route (provider referral) satisfies ethical duty and protects clinician.

— Child abuse → CPS (every state, all healthcare workers).

— Elder/dependent adult abuse → APS.

— Gunshot/stab wounds → law enforcement.

— Impaired drivers (e.g., seizures, dementia) → DMV in some states.

— Tarasoff duty to warn identified third-party threats from a psychiatric patient.

— When transferring a patient with active TB or measles between facilities, transport must be notified for airborne precautions; the receiving facility's IP team must be informed before arrival — a frequent Step 3 patient-safety item.

— Discharge summary should explicitly note "reported to [state] DOH on [date]" to prevent duplicate or omitted reporting in the longitudinal record.

Key distinction: A patient with newly diagnosed HIV who refuses to tell her partner does not override your duty — but reporting to the health department (which then performs anonymous partner notification) is the correct, legally protective answer. Do not personally call the partner.

Reporting sits at the intersection of confidentiality, autonomy, and beneficence. Step 3 commonly tests these tensions.

HIPAA and confidentiality

Partner notification

Duty to warn and Tarasoff-style overlap

Mandatory reporting beyond public health

Transition-of-care safety

High-Yield Associations and Rapid-Fire Clinical Facts

— Brucellosis → unpasteurized dairy, livestock workers — reportable.

— Tularemia → rabbit/tick exposure, lab accident — immediately reportable.

— Q fever (Coxiella) → parturient livestock — reportable.

— Hantavirus → rodent droppings, southwestern US — reportable.

— Leptospirosis → freshwater exposure, triathletes, Hawaii — reportable.

— Anthrax → wool, hides, mail (bioterrorism) — immediately reportable.

— Plague → prairie dogs, fleas, southwestern US — immediately reportable.

— Vibrio vulnificus → raw oysters, cirrhotic patient with septic shock — reportable.

— RMSF → centripetal rash starting wrists/ankles, doxycycline even in kids — reportable.

— Ehrlichiosis → morulae in monocytes — reportable.

— Anaplasmosis → morulae in granulocytes — reportable.

— Babesiosis → Maltese cross on smear, asplenic patient — reportable.

— Listeria → meningitis in neonates/elderly/pregnant; ampicillin + gent — reportable.

— Measles R₀: 12–18; pertussis 5–7; COVID-19 original 2–3.

— Vitamin A in measles: 200,000 IU × 2 days (>12 mo).

— Blood lead reference: 3.5 µg/dL (CDC, 2021).

— Latent TB therapy adherence target: 90%+ for completion credit.

— Ceftriaxone for gonorrhea: 500 mg IM (or 1 g if ≥150 kg).

— Syphilis cure: 4-fold RPR drop in 6–12 months.

Step 3 management: The phrase "unpasteurized goat cheese in a returning traveler with undulating fever" = brucellosis = doxycycline + rifampin × 6 weeks + report, with occupational and lab-exposure investigation if relevant.

Rapid-fire associations that frequently anchor Step 3 vignettes.

Disease ↔ classic exposure

Disease ↔ classic finding

Numbers worth memorizing

Bioterrorism Category A list: anthrax, botulism, plague, smallpox, tularemia, viral hemorrhagic fevers — all immediately notifiable.

Board Question Stem Patterns

— Clinical syndrome strongly suggests a reportable disease + treatment already begun → answer is usually "notify the local/state health department" or "begin contact tracing."

— Distractors: "obtain consent for reporting" (wrong — not needed), "wait for confirmatory test" (wrong — report on suspicion), "discharge with follow-up" (wrong — incomplete).

— Patient says, "Don't tell anyone." Question tests whether you know public health reporting is exempt.

— Correct answer: report and inform the patient that reporting is required by law.

— Stem describes gunshot wound, child abuse, vaccine reaction, drug side effect, or infectious disease — pick the correct reporting channel (police, CPS, VAERS, MedWatch, health dept).

— Index case identified — question asks about household/close contact management.

— Common answers: rifampin/cipro for meningococcal contacts; macrolide for pertussis contacts; MMR within 72 h for measles contacts; HBIG+vaccine for HBV exposure; doxycycline for anthrax exposure.

— Asks when child or food handler may return — match to the disease-specific exclusion period.

— Three children at the same daycare with bloody diarrhea — answer is stool studies + report + cohort/exclude affected children + environmental investigation triggered by health department.

— Syphilis in penicillin-allergic pregnant patient → desensitize and treat with penicillin.

— HBsAg+ mother → HBIG + vaccine to infant within 12 h.

— Multiple patients with mediastinal widening (anthrax), descending paralysis (botulism), or pustular rash centrifugal (smallpox) → immediately call CDC + state health dept.

Board pearl: When the question stem ends with "...and the patient asks that this not be reported," 19 times out of 20 the right answer is reassure, explain the legal duty, and report anyway.

Recognizing stem archetypes accelerates the right reflex.

Pattern 1: "What is the most appropriate next step?"

Pattern 2: HIPAA/confidentiality conflict

Pattern 3: Channel selection

Pattern 4: Contact prophylaxis

Pattern 5: Return to school/work

Pattern 6: Outbreak recognition

Pattern 7: Pregnancy + reportable infection

Pattern 8: Bioterrorism trigger

One-Line Recap

Reportable diseases require clinician-initiated notification of public health authorities on the basis of clinical suspicion — not laboratory confirmation, not patient consent, not provider discretion — because surveillance, contact tracing, and post-exposure prophylaxis depend on timely reports that are explicitly permitted by HIPAA's public health exception.

Tiers: Category A bioterrorism agents, measles, meningococcal disease, novel influenza A, polio, rabies, and suspected outbreaks are immediately notifiable (phone, often within hours); STIs, hepatitis, vector-borne diseases, and most enteric pathogens are routinely notifiable (within ~1 week via electronic lab reporting).

Channels: state/local health department for infectious and environmental conditions; VAERS for vaccine adverse events; MedWatch for drug adverse events; CPS for child abuse; APS for elder abuse; law enforcement for gunshot/stab wounds; cancer registry for malignancies; CDC EOC (770-488-7100) for antitoxins (diphtheria, botulism) and Category A agents.

Parallel actions: empiric treatment, isolation precautions (airborne for TB/measles/varicella; droplet for meningococcus/pertussis), contact prophylaxis (rifampin/cipro for meningococcal contacts, macrolide for pertussis contacts, MMR within 72 h or IVIG within 6 days for measles contacts), and reporting all happen simultaneously — never sequentially delayed.

Step 3 reflex: if the stem says "don't tell anyone," "wait for the test," or "let me think about it," the answer is to report now, treat now, isolate now — patient safety, population health, and legal duty converge on a single correct action.